| JYHB2002708 | 替格瑞洛分散片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2020-12-29 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2021-01-15 | view |
| JXHS1900067 | 替格瑞洛分散片 | ticagrelor | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2019-05-24 | | AstraZeneca AB | Certificate Issued | 2020-09-07 | view |
| JXHL1700149 | 替格瑞洛分散片 | ticagrelor | Tablet | Chemical Drugs(5.1) | Import Drug Application | 2017-08-16 | AstraZeneca AB | AstraZeneca AB | In Review | 2017-08-15 | view |
| CXHL1501636 | 替格瑞洛分散片 | ticagrelor | Tablet | Chemical Drugs(5) | New Drug Application | 2015-10-08 | 天津汉瑞药业有限公司 | Tianjin Hanrui Pharmaceutical Co Ltd | Certificate Issued | 2016-07-21 | view |
| JYHB2200506 | 替格瑞洛分散片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2022-09-15 | | AstraZeneca AB | | | view |
| CYHS2303673 | 替格瑞洛分散片 | ticagrelor | Tablet | Chemical Drugs(4) | Generic Drug | 2023-12-29 | | Tianjin Lisheng Pharmaceutical Co Ltd | | | view |
| CYHS2101378 | 替格瑞洛分散片 | ticagrelor | Tablet | Chemical Drugs(4) | Generic Drug | 2021-07-05 | | | | | view |
| CYHS2201152 | 替格瑞洛分散片 | ticagrelor | Tablet | Chemical Drugs(4) | Generic Drug | 2022-07-27 | | | | | view |
| JYHB2101438 | 替格瑞洛分散片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2021-09-23 | | AstraZeneca AB | | | view |
| JYHB2200107 | 替格瑞洛分散片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2022-03-03 | | AstraZeneca AB | | | view |
| JYHZ2400273 | 替格瑞洛分散片 | ticagrelor | Tablet | Chemical Drugs | License Renew | 2024-10-12 | | | | | view |
| CYHS2201614 | 替格瑞洛分散片 | ticagrelor | Tablet | Chemical Drugs(4) | Generic Drug | 2022-09-27 | | Kunming Longjin Pharmaceutical Co Ltd | | | view |
| JYHB2400399 | 替格瑞洛分散片 | ticagrelor | Tablet | Chemical Drugs | Supplementary Application | 2024-07-27 | | AstraZeneca AB | | | view |
